Suppr超能文献

罕见病患者的诊断时间和诊断延迟的决定因素:罕见病晴雨表回顾性患者调查结果。

Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey.

机构信息

EURORDIS-Rare Diseases Europe, Paris, France.

HHT Europe, Roma, Italy.

出版信息

Eur J Hum Genet. 2024 Sep;32(9):1116-1126. doi: 10.1038/s41431-024-01604-z. Epub 2024 May 16.

Abstract

Timely diagnosis is one of the most serious challenges faced by people living with a rare disease (PLWRD), and this study estimates that in Europe, the average total diagnosis time (TDT) is close to 5 years. We investigated the duration of the TDT for PLWRD in Europe, the difficulties associated with their diagnosis odyssey and the main determinants of diagnosis delays for all rare diseases (RD). We conducted a survey of PLWRD and their families using Rare Barometer, the survey initiative of EURORDIS-Rare Diseases Europe. In geographical Europe, we surveyed 6507 people living with 1675 RD in 41 countries. We then performed a descriptive analysis and ordinal logistic regressions to identify the main determinants of diagnosis delays. Average TDT is 4.7 years. 56% of respondents were diagnosed more than 6 months after a first medical contact. The main determinants of diagnosis delays are symptom onset before 30 years of age, especially during childhood (OR = 3.11; 95% CI: 2.4-4.0) and adolescence (OR = 4.79; 95% CI: 3.7-6.2), being a woman (OR = 1.22; 95% CI:1.1-1.4), living in Northern Europe (OR = 2.15; 95% CI:1.8-2.6) or Western Europe (OR = 1.96; 95% CI:1.6-2.3), the number of healthcare professionals consulted (OR = 5.15; 95% CI:4.1-6.4), misdiagnosis (OR = 2.48; 95% CI:2.1-2.9), referral to a centre of expertise (OR = 1.17; 95% CI:1.0-1.3), unmet needs for psychological support (OR = 1.34; 95% CI:1.2-1.5) and financial support (OR = 1.16; 95% CI:1.0-1.3), having a genetic disease (OR = 1.33; 95% CI:1.1-1.5) and a family history of an RD (OR = 1.36; 95% CI:1.1-1.6). These determinants can inform policies and actions to improve access to diagnosis for all PLWRD.

摘要

及时诊断是罕见病患者(PLWRD)面临的最严峻挑战之一,本研究估计,在欧洲,罕见病的平均总诊断时间(TDT)接近 5 年。我们调查了欧洲罕见病患者的 TDT 持续时间、诊断困难以及所有罕见病(RD)诊断延迟的主要决定因素。我们使用 EURORDIS-Rare Diseases Europe 的调查计划 Rare Barometer 对 PLWRD 及其家属进行了调查。在地理上的欧洲,我们在 41 个国家调查了 6507 名患有 1675 种 RD 的患者。然后,我们进行了描述性分析和有序逻辑回归,以确定诊断延迟的主要决定因素。平均 TDT 为 4.7 年。56%的受访者在首次就诊后 6 个月以上才被诊断出疾病。诊断延迟的主要决定因素是 30 岁前发病,尤其是儿童期(OR=3.11;95%CI:2.4-4.0)和青春期(OR=4.79;95%CI:3.7-6.2),女性(OR=1.22;95%CI:1.1-1.4),居住在北欧(OR=2.15;95%CI:1.8-2.6)或西欧(OR=1.96;95%CI:1.6-2.3),就诊的医护人员数量(OR=5.15;95%CI:4.1-6.4),误诊(OR=2.48;95%CI:2.1-2.9),转诊至专科中心(OR=1.17;95%CI:1.0-1.3),心理支持需求未得到满足(OR=1.34;95%CI:1.2-1.5)和财务支持(OR=1.16;95%CI:1.0-1.3),患有遗传疾病(OR=1.33;95%CI:1.1-1.5)和家族中存在 RD(OR=1.36;95%CI:1.1-1.6)。这些决定因素可以为改善所有 PLWRD 的诊断提供政策和行动信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f800/11369105/685e79599ebc/41431_2024_1604_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验